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Abstract
AIM: Helicobacter pylori (H pylori) is associated with
increased gastric inflammatory and epithelial expression
of macrophage migration inhibitory factor (MIF) and
gastric epithelial cell proliferation. This study aimed at
determining whether H pylori directly stimulates release
of MIF in monocytes, whether the cag pathogenicity island
(PAI) is involved for this function, and whether MIF
stimulated by H pylori increases gastric epithelial cell
proliferation in vitro.
METHODS: A cytotoxic wild-type H pylori strain (TN2)
and its three isogenic mutants (TN2△cag, TN2△cagA
and TN2△cagE) were co-cultured with cells of a human
monocyte cell line, THP-1, for 24 h at different organism/
cell ratios. MIF in the supernatants was measured by an
ELISA. Cells of a human gastric cancer cell line, MKN45,
were then co-cultured with the supernatants, with and
without monoclonal anti-MIF antibody for 24 h. The cells
were further incubated for 12 h after addition of 3H-
thymidine, and the levels of incorporation of 3H-thymidine
were measured with a liquid scintillation counter.
RESULTS: The wild-type strain and the isogenic mutants,
TN2△cagA and TN2△cagE, increased MIF release at
organism/cell ratios of 200/1 and 400/1, but not at the
ratios of 50/1 and 100/1. However, the mutant TN2△cag
did not increase the release of MIF at any of the four ratios.
3H-thymidine readings for MKN-45 cells were significantly
increased with supernatants derived from the wild-type
strain and the mutants TN2△cagA and TN2△cagE, but
not from the mutant TN2△cag. Moreover, in the presence
of monoclonal anti-MIF antibody, the stimulatory effects of
the wild-type strain on cell proliferation disappeared.
CONCLUSION: H pylori stimulates MIF release in
monocytes, likely through its cag PAI, but not related to
cagA or cagE. H pylori-stimulated monocyte culture
supernatant increases gastric cell proliferation, which is
blocked by anti-MIF antibody, suggesting that MIF plays
an important role in H pylori-induced gastric epithelial
cell proliferation.
© 2005 The WJG Press and Elsevier Inc. All rights reserved.
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INTRODUCTION
Migration inhibitory factor (MIF) plays a pivotal role in
inflammatory and immune diseases such as septic shock,
rheumatoid arthritis, atopic dermatitis, glomerulonephritis,
ulcerative colitis and alcoholic hepatitis[1-4]. In our previous
study, MIF was markedly up-regulated during acute gastric
ulceration in rats, which was associated with accumulation
of macrophages in gastric mucosa[5]. Blockade with the
neutralizing anti-MIF antibody inhibited macrophage
accumulation and MIF up-regulation, indicating an important
pathogenic role of MIF in gastric inflammation and
ulceration[5]. Recently, studies have indicated that MIF may
also play a critical role as a cytokine in the development of
cancers as a link between inflammation and tumorigenesis[1,6,7].
It has been reported that MIF is increasingly expressed in
cells of several tumors, including melanoma, neuroblastoma,
myelomonocytic leukemia, prostatic cancers of breast, colon,
lung, liver, stomach and esophagus, suggesting its
involvement in carcinogenesis[1,6-11], although the precise role
of MIF in tumor cells remains unclear. In addition, our
studies also demonstrated increased serum levels and gastric
epithelial expression of MIF in gastric cancer[12].
Helicobacter pylori (H pylori) is a bacterium that colonizes
the human stomach and causes gastric inflammation and peptic
ulcer disease. Moreover, epidemiological and experimental
evidence have proven that infection with H pylori, especially
those with cagA gene (a marker of the cag pathogenicity island
(PAI)), plays an important role in gastric carcinogenesis[13-16].
We observed that H pylori infection increased MIF expression
in both gastric inflammatory and epithelial cells[17]; thus, we
hypothesize that H pylori infection may contribute to gastric
carcinogenesis, in part, through an MIF-mediated pathway.
Therefore, the aim of  this study was to determine whether
H pylori directly stimulates release of MIF in monocytes,
whether the cag PAI is involved in this function, and whether
MIF stimulated by H pylori increases gastric epithelial cell
proliferation in vitro.
MATERIALS AND METHODS
H pylori strains and cell lines
H pylori strain (TN2) and its three isogenic mutants (TN2
△cag, TN2△cagA and TN2△cagE) were used in the study.
TN2, a strain positive for vacuolating cytotoxin and cag PAI,
shares an ancestral strain with TN2GF4, which was previously
reported to induce gastric cancer in Mongolian gerbils[16]. THP-
1 (American type culture collection, ATCC, Manassas, VA,
USA), a human monocyte cell line derived from acute
monocyte leukemia and widely applied for in vitro experiments,
was used for the determination of  the effect of  H pylori on
MIF release. MKN45 (The RIKEN Cell Bank, The Institute
of Physical and Chemical Research, Japan), a poorly
differentiated human gastric cancer cell line with wild type
p53, was used for the determination of  the effect of  H pylori-
stimulated MIF on gastric cell proliferation.
Culture of bacterial cells and preparation of whole cell proteins
The bacterial cells of the strain TN2 and its isogenic mutants
were cultured on blood agar plates in microaerophilic
conditions, and then subcultured in liquid medium for three
days, as previously described[18]. The liquid culture was
transferred into a 50-mL centrifuge tube, centrifuged at
10 000 g for 10 min at 4 ℃ and washed thrice with 10 mL
RPMI 1640. The pellet was suspended in 1 mL RPMI 1640,
and frozen at -20℃ and thawed thrice at 37 ℃. The cells
were then sonicated on ice at the maximum power for 12
cycles, with 20 s on and 10 s off in each cycle. The suspension
was centrifuged at 12 000 g for 15 min at 4 ℃, and the
supernatant was transferred into an Eppendorf tube, and
the whole cell protein content measured using the BCA Protein
Assay Kit (Gene Company Limited, Hong Kong, China). The
supernatant was kept at -70 ℃ until use.
Co-culture of THP-1 with whole cell proteins of H pylori or live
H pylori cells
THP-1 cells were cultured in RPMI 1640 medium (10%
fetal bovine serum, 100 U/mL penicillin, 100 g/mL
streptomycin and 2 g/mL NaHCO3) at 37 ℃ in a 50 mL/L
CO2 - 95 mL/L O2 incubator, collected by using trypsin
when they reached 80% confluence, and then adjusted to
the concentration of 1×105 cells/mL. The cells (100 L)
were added into wells of 24-well microtiter tray, and then
incubated at 37℃ for 12 h. The whole cell protein
preparations (diluted in RPMI 1640 medium with a final
concentration of 40 g/mL), live H pylori organisms (at
organism/cell ratios of 50/1, 100/1, 200/1 and 400/1) were
added to THP1 culture. Lipopolysaccharide (Sigma Chemical
Co., St. Louis, MO), known to activate THP-1 cells and
stimulate MIF release[19,20], was used as a positive control,
and RPMI 1640 medium was used as a negative control. In
our pilot experiments, the concentration of 1 ng/mL was
found to be the lowest concentration that reached the
maximum stimulatory effect, and thus was used in the further
study. THP1 cells were further incubated for 24 h, and culture
supernatants were collected at 6, 12 and 24 h, and stored at
-20 ℃ after centrifugation until use.
Measurement of MIF proteins using enzyme-linked
immunosorbent assay
MIF in the supernatants was measured by an ELISA
according to the manufacturer’s instruction (R&D Systems,
Inc., Minneapolis, MN). Briefly, 100 L of capture anti-
human MIF antibody (2 g/mL) in phosphate-buffered
saline (PBS, pH7.4) was transferred into each well of an
ELISA plate, blocked with 1% BSA. Hundred microliters of
each sample, or recombinant human MIF (R&D Systems,
Inc.) were added, in triplicate, into corresponding wells for
2 h at room temperature. Biotinylated anti-human MIF
antibody (0.2 g/mL, R&D Systems, Inc.) was added, and
incubated for 2 h at room temperature. After plates were
washed thrice, 100 L streptavidin-HRP (R&D System, Inc.)
at a dilution of  1 in 200 was added into each well. Following
further washing for four times, 100 L of 1:1 mixture of
reagents A (H2O2) and B (tetramethylbenzidine) was added.
Finally, the reaction was stopped by adding 50 L of H2SO4.
Absorbance was read using a microtiter plate reader
(NovaPathTM, BIO-RAD, Hercules, CA) set at 450 nm.
Proliferation of gastric epithelial cells
After MKN-45 cells were cultured in RPMI 1640 medium
at 37 ℃ for 24 h to reach a confluent monolayer, the above-
prepared THP1 culture supernatants were added with a
final concentration of 20% in the medium, with or without
monoclonal anti-MIF antibody (1 ng/mL, R&D System,
Inc.). RPMI 1640 medium was used as a negative control.
The cells were further incubated for 24 h, and then 3H-
thymidine (50c) was added to the medium, and the
cells were incubated for additional 12 h. The levels of
incorporation of 3H-thymidine of the MKN-45 during the
last 12 h were determined in a liquid scintillation counter
(Beckman LS 6 500, Beckman Instruments, Inc., Fullerton,
CA) as counts per minute (cpm).
Statistical analysis
Data obtained from the study were expressed as the
mean±SD. Statistical analysis was performed using SPSS
software (version 10.0, SPSS Inc., Chicago, IL). Independent
samples t-test, or the Mann-Whitney U test, where
appropriate, was used to determine the differences in
numeric variables. P values calculated were two-tailed. The
alpha level of significance was set at P<0.05.
RESULTS
Effect of H pylori on the MIF expression
Secretion of MIF by THP-1 cells was significantly increased
by the whole cell proteins of the wild-type TN2 strain, cagA-
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deleted or cagE-deleted mutants in a time-dependent manner
(Figure 1). However, the whole cell proteins of  PAI-deleted
mutants did not have the stimulatory effect on MIF secretion
(Figure 1). Similarly, co-culture of live organisms of the
wild-type strain, cagA-deleted or cagE-deleted mutants
significantly increased MIF secretion in a dose-dependent
manner (Figure 2). However, the PAI-deleted mutant had
no effect on MIF secretion (Figure 2).
Effect of H pylori-stimulated MIF on gastric epithelial cell
proliferation
Proliferation of MKN-45 cells was significantly increased
by adding the supernatant of co-culture of THP-1 with
LPS or with the wild-type strain (Figure 3). The supernatant
of  co-culture of  THP-1 with the PAI-deleted mutant only
slightly increased cell proliferation (Figure 3). Interestingly,
addition of monoclonal anti-MIF antibody decreased cell
proliferation of  the gastric cancer cells. Furthermore, the
stimulatory effect of LPS and the wild-type H pylori strain
on the cell proliferation was completely abolished by the
addition of the antibody (Figure 3).
DISCUSSION
The present study shows that either the whole cell proteins or
live organisms of the cytotoxic H pylori strain stimulate the
monocytes to release MIF. In addition, the cag PAI-deleted
mutant has little effect on the MIF release, suggesting the
essential role of  PAI in the stimulation of  MIF release.
Moreover, the supernatant of H pylori co-cultured monocytes
increases proliferation of gastric cancer cells and neutralizing
monoclonal anti-MIF antibody reduces cell proliferation,
indicating that MIF plays an important role in gastric cell
proliferation.
Studies have shown that MIF is a pro-inflammatory
cytokine and is constitutively expressed, stored in a preformed
manner in cytoplasm, and released into circulation upon
stimulation[21]. It has been reported that normal gastric epithelial
cells constitutively, albeit weakly, express MIF[5,17,22]. In our
previous study, we observed that MIF expression was
significantly increased in gastric epithelial cells in the presence
of H pylori infection[17]. More importantly, it is well known that
preformed MIF protein is present in both resting macrophages
and monocytes, indicating that the macrophage is not only a
target, but also a source of MIF in vivo[2,21,23,24]. It is well
established that H pylori infection is associated with gastric
infiltration of acute and chronic inflammatory cells, including
microphages and monocytes. Previously, we applied a double
staining technique to simultaneously detect activated T cells
(CD45RO) and macrophages (KP-1) and observed increased
MIF expression in these cells in gastric mucosa[17]. In present
in vitro study, we clearly show that H pylori stimulated release
of  MIF by monocytes, most likely through its cag PAI.
However, both cagA and cagE appeared not to play a role in
the stimulatory effect, since cagA- or cagE-deleted mutant
possess the similar stimulatory effect on MIF release to their
parent. MIF may play an important role in gastric inflammation
and injury. We hypothesize that colonization of  H pylori in
the stomach directly stimulates the gastric epithelial cells to
release MIF, which then promotes local infiltration of
inflammatory cells including neutrophils, T- and B-
lymphocytes and macrophages, resulting in the production
of inducible nitrite oxide synthase (iNOS) and cytotoxic
cytokines such as TNF-, IFN-and ICAM-1[1,5,19,25,26].
Consequently, activated T-cells and macrophages per se
release a large amount of MIF. In the presence of chronic
H pylori infection, this cycle continues, which contributes to
more severe inflammation, and gastric injury such as gastric
erosion and ulcerations.
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Figure 2  Expression of MIF by THP1 after co-culture with a wild-
type cytotoxic H pylori strain TN2 and its isogenic mutants, TN2△
cag (PAI-), TN2△cagA (cagA-) and TN2△cagE (cagE-), at different or-
ganism/cell ratios for 12 h. The bars represent the standard deviations.
bP<0.01, compared with the isogenic mutant TN2△cag (PAI-).
Figure 3  Effect of LPS and H pylori-co-cultured supernatants of
THP1 cells, with and without addition of monoclonal anti-MIF anti-
body (Ab), on the cell proliferation of MKN-45. The bars represent
the standard deviations. aP<0.05 vs the control.ure 3
Figure 1  Expression of MIF by THP1 after co-culture with LPS (1 ng/mL)
and whole cell proteins (40 g/mL) of wild-type cytotoxic H pylori
strain TN2 and its isogenic mutants, TN2△cag (PAI-), TN2△cagA
(cagA-) and TN2△cagE (cagE-). The bars represent the standard
deviations. bP<0.01, compared with the control.
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Recently, we demonstrated that MIF expression was
significantly increased in precancerous lesions and gastric
cancer, suggesting its role in gastric carcinogenesis[12]. MIF
could be involved in carcinogenesis, by promoting cell
proliferation, tumor angiogenesis and metastasis [1,8,26-30]. In
previous animal studies, it was observed that increased MIF
expression was associated with enhanced proliferation of
murine colon cancer cells in response to growth factors and
neutralizing anti-MIF-antibodies dramatically reduce the initial
outgrowth of 38C13 B cell lymphoma cells in mice[26,27]. MIF
has been identified as an angiogenic factor and neutralization
of MIF by anti-MIF antibodies inhibits endothelial cell growth
and leads to a reduced number of tumor capillaries[27,28].
Inhibition of angiogenesis by anti-MIF antibody treatment
has also been reported in a human melanoma model and in
murine colon carcinoma cells[8,26,29]. Both increased
proliferation of tumor cells and angiogenesis would inevitably
result in metastasis. In the present study, we observed that
supernatant of monocytes after co-culture with H pylori
increased proliferation of gastric cancer cells, and addition
of anti-MIF antibody blocked the increase in cell
proliferation, suggesting MIF stimulated by H pylori plays
an important role in gastric epithelial cell proliferation. How
MIF regulates cell proliferation is under intensive
investigation. Recent studies suggest that modulation of  cell
proliferation by MIF could involve a complex regulatory
system, in which proteins p53, JAB/CSN5/p27Kip1 and
ERK1/2, and possibly other signalosome proteins, may play
important roles[1,6,7,30,31].
Genetic analysis reveals that H pylori strains can be divided
into two types, by the presence or absence of a 40 kb of
foreign DNA, i.e., the cag PAI which consists of  at least 18
open-reading frames such as cagA, cagE, etc.[32]. Over the past
decade, cagA, a 120-128 ku protein, has been identified as a
marker for the presence of  cag PAI[33,34]. Upon contact with
gastric epithelial cells, cagA is translocated into gastric epithelial
cells, where cagA undergoes tyrosine phosphorylation and
recruits and activates Src homology phosphatase 2, thereby
inducing a growth-factor-like effect[34]. Recent studies have
indicated that cagE and several other genes of  cag PAI code a
type IV secretion system, which is involved in the translocation
of cagA protein into the gastric epithelial cells[34-36]. Moreover,
isogenic mutant studies demonstrated that some cag PAI genes,
including cagE, are essential for interleukin-8 induction and
nuclear factor-B activation[32,34,37,38]. However, a recent study
found that the association between cagE genotype and IL-8
induction was weak and implied that gastric cell factors or
other bacterial factors are involved in the induction of IL-8[39].
In animal studies, it was observed that knocking out of  cagE
gene deprived wild-type H pylori of the pathogenicity for
gastritis and gastric ulcer in Mongolian gerbils, suggesting
that this gene is responsible for various gastric lesions[40,41].
Day et al[42], reported that cagE is associated with H pylori-
induced duodenal ulceration in children in Canada.
However, studies in Japan and Taiwan showed that presence
of cagE appeared not to be related to the severity of gastric
mucosal inflammation and ulceration in patients with upper
gastroduodenal symptoms since almost all isolates were cagE
positive[43-45]. In the present study, we demonstrated that cag
PAI is essential for the stimulation of  MIF secretion.
However, neither cagA nor cagE is involved in the
stimulation, suggesting that genes other than cagA and cagE
in the cag PAI are responsible for this function.
In conclusion, H pylori stimulates MIF release in
monocytes, likely through its cag PAI, but not related to
cagA and cagE. H pylori-stimulated monocyte culture
supernatant increases gastric cell proliferation, which is
blocked by anti-MIF antibody, suggesting that MIF plays
an important role in H pylori-induced gastric epithelial cell
proliferation.
ACKNOWLEDGMENTS
The authors wish to thank Dr. Xing-Xiang He of the
Department of Medicine, The Second Affiliated Hospital
of Guangzhou Medical College, Guangzhou, China for
performing  the experiments. Part of  the results in the study
was presented at the Digestive Disease Week of  the American
Gastroenterological Association, Orlando, 17-22 May 2003.
Gastroenterology 2003; 124: A269 and Gastroenterology 2003;
124: A594.
REFERENCES
1 Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J. Mac-
rophage migration inhibitory factor (MIF): mechanisms of
action and role in disease. Microbes Infect 2002; 4: 449-460
2 Lan HY, Yang N, Nikolic-Paterson DJ, Yu XQ, Mu W, Isbel
NM, Metz CN, Bucala R, Atkins RC. Expression of macroph-
age migration inhibitory factor in human glomerulonephritis.
Kidney Int 2000; 57: 499-509
3 de Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K,
Rietdijk ST, Faubion WA, Mizoguchi E, Metz CN, Alsahli M,
ten Hove T, Keates AC, Lubetsky JB, Farrell RJ, Michetti P,
van Deventer SJ, Lolis E, David JR, Bhan AK, Terhorst C.
Development of chronic colitis is dependent on the cytokine
MIF. Nat Immunol 2001; 2: 1061-1066
4 Kumagi T, Akbar F, Horiike N, Onji M. Increased serum
levels of macrophage migration inhibitory factor in alcoholic
liver diseases and their expression in liver tissues. Clin Biochem
2001; 34 : 189-193
5 Huang XR, Chun Hui CW, Chen YX, Wong BC, Fung PC,
Metz C, Cho CH, Hui WM, Bucala R, Lam SK, Lan HY.
Macrophage migration inhibitory factor is an important me-
diator in the pathogenesis of gastric inflammation in rats.
Gastroenterology 2001; 121: 619-630
6 Mitchell RA, Bucala R. Tumor growth-promoting proper-
ties of macrophage migration inhibitory factor (MIF). Semin
Cancer Biol 2000; 10: 359-366
7 Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ,
Beach DH. A proinflammatory cytokine inhibits p53 tumor
suppressor activity. J Exp Med 1999; 190: 1375-1382
8 Bin Q, Johnson BD, Schauer DW, Casper JT, Orentas RJ.
Production of macrophage migration inhibitory factor by
human and murine neuroblastoma. Tumour Biol 2002; 23 :
123-129
9 Meyer-Siegler KL, Bellino MA, Tannenbaum M. Macroph-
age migration inhibitory factor evaluation compared with pros-
tate specific antigen as a biomarker in patients with prostate
carcinoma. Cancer 2002; 94: 1449-1456
1 0 Akbar SM, Abe M, Murakami H, Tanimoto K, Kumagi T,
Yamashita Y, Michitaka K, Horiike N, Onji M. Macrophage
migration inhibitory factor in hepatocellular carcinoma and
liver cirrhosis; relevance to pathogenesis. Cancer Lett 2001;
171: 125-132
1 1 Xia HH, Zhang ST, Lam SK, Lin MC, Kung HF, Wong BC.
Expression of macrophage migration inhibitory factor in esoph-
ageal squamous cell carcinoma and effects of bile acids and
Xia HHX et al. H pylori-stimulated MIF increases gastric proliferation                        1949
NSAIDs. Carcinogenesis 2005; 26: 11-15
1 2 He XX, Xia HHX, Yang Y, Lam SK, Lin MCM, Wong WM,
Kung HF, Leung SY, Yuen ST, Zhao YH, Wong BCY. Increased
serum levels and epithelial expression of macrophage migra-
tion inhibitory factor in gastric cancer. Gastroenterology 2003;
124: A556
1 3 Xia HHX, Wong BCY, Lam SK. Helicobacter pylori infection
and gastric cancer. Asian J Surg 2001; 24: 217-221
1 4 Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association
of Helicobacter pylori infection with gastric carcinoma: a meta-
analysis. Am J Gastroenterol 1999; 94: 2373-2379
1 5 Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-
analysis of the relationship between cagA seropositivity and
gastric cancer. Gastroenterology 2003;125: 1636-1644
1 6 Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter
pylori infection induces gastric cancer in mongolian gerbils.
Gastroenterology 1998; 115: 642–648
1 7 Xia HH, Lam SK, Huang XR, Wong WM, Leung SY, Yuen ST,
Lan HY, Wong BC. Helicobacter pylori infection is associated
with increased expression of macrophage migration inhibi-
tory factor by epithelial cells, T cells and macrophages in
gastric mucosa. J Infect Dis 2004; 190: 293-302
1 8 Xia HX, English L, Keane CT, O’Morain CA. Enhanced culti-
vation of Helicobacter pylori in liquid media. J Clin Pathol 1993;
46 : 750-753
1 9 Perez-Perez GI, Shepherd VL, Morrow JD, Blaser MJ. Acti-
vation of human THP-1 cells and rat bone marrow-derived
macrophages by Helicobacter pylori lipopolysaccharide. Infect
Immun 1995; 63 : 1183-1187
2 0 Nishihira J, Koyama Y, Mizue Y. Identification of macroph-
age migration inhibitory factor in human leukemia HL-60
cells and its induction by lipopolysaccharide. Biochem Mol
Biol Int 1996; 40: 861-869
2 1 Calandra T, Spiegel LA, Metz CN, Bucala R. Macrophage
migration inhibitory factor is a critical mediator of the activa-
tion of immune cells by exotoxins of Gram-positive bacteria.
Proc Natl Acad Sci USA 1998; 95: 11383-11388
2 2 Maaser C, Eckmann L, Paesold G, Kim HS, Kagnoff MF.
Ubiquitous production of macrophage migration inhibitory
factor by human gastric and intestinal epithelium. Gastroen-
terology 2002; 122: 667-680
2 3 Calandra T, Bernhagen J, Mitchell RA, Bucala R. The mac-
rophage is an important and previously unrecognized source
of macrophage migration inhibitory factor. J Exp Med 1994;
179: 1895-1902
2 4 Lan HY, Bacher M, Yang N, Mu W, Nikolic-Paterson DJ,
Metz C, Meinhardt A, Bucala R, Atkins RC. The pathogenic
role of macrophage migration inhibitory factor in immuno-
logically induced kidney disease in the rat. J Exp Med 1997;
185: 1455-1465
2 5 Swope MD, Lolis E. Macrophage migration inhibitory factor:
cytokine, hormone, or enzyme? Rev Physiol Biochem Pharmacol
1999; 139: 1-32
2 6 Takahashi N, Nishihira J, Sato Y, Kondo M, Ogawa H,
Ohshima T, Une Y, Todo S. Involvement of macrophage mi-
gration inhibitory factor (MIF) in the mechanism of tumor cell
growth. Mol Med 1998; 4: 707-714
2 7 Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala
R. An essential role for macrophage migration inhibitory fac-
tor (MIF) in angiogenesis and the growth of a  murine
lymphoma. Mol Med 1999; 5: 181-191
2 8 Yang Y, Degranpre P, Kharfi A, Akoum A. Identification of
macrophage migration inhibitory factor as a potent endothe-
lial cell growth-promoting agent released by ectopic human
endometrial cells. J Clin Endocrinol Metab 2000; 85: 4721-4727
2 9 Ogawa H, Nishihira J, Sato Y, Kondo M, Takahashi N, Oshima
T, Todo S. An antibody for macrophage migration inhibitory
factor suppresses tumour growth and inhibits tumour-asso-
ciated angiogenesis. Cytokine 2000; 12: 309-314
3 0 Kleemann R, Hausser A, Geiger G, Mischke R, Burger-
Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T,
Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J.
Intracellular action of the cytokine MIF to modulate AP-1 ac-
tivity and the cell cycle through Jab1. Nature 2000; 408: 211-216
3 1 Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh
J, David J, Bucala R. Macrophage migration inhibitory factor
(MIF) sustains macrophage proinflammatory function by in-
hibiting p53: regulatory role in the innate immune response.
Proc Natl Acad Sci USA 2002; 99: 345-350
3 2 Censini S ,  Lange C, Xiang Z, Crabtree JE, Ghiara P,
Borodovsky M, Rappuoli R, Covacci A. cag, a pathogenicity
island of Helicobacter pylori, encodes type I-specific and dis-
ease-associated virulence factors. Proc Natl Acad Sci USA 1996;
93 : 14648-14653
3 3 Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D,
Macchia G, Massone A, Papini E, Xiang Z, Figura N. Molecu-
lar characterization of the 128-kDa immunodominant antigen
of Helicobacter pylori associated with cytotoxicity and duode-
nal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5795
3 4 Hatakeyama M. Oncogenic mechanisms of the Helicobacter
pylori CagA protein. Nat Rev Cancer 2004; 4: 688-694
3 5 Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation
of the Helicobacter pylori CagA antigen after cag-driven host
cell translocation. Proc Natl Acad Sci USA 2000; 97: 1263-1268
3 6 Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas
R. Translocation of Helicobacter pylori CagA into gastric epi-
thelial cells by type IV secretion. Science 2000; 287: 1497-1500
3 7 Tummuru MK, Sharma SA, Blaser MJ. Helicobacter pylori picB,
a homologue of the Bordetella pertussis toxin secretion protein,
is required for induction of IL-8 in gastric epithelial cells. Mol
Microbiol 1995; 18: 867-876
3 8 Maeda S, Yoshida H, Ogura K, Mitsuno Y, Hirata Y, Yamaji
Y, Akanuma M, Shiratori Y, Omata M. H pylori activates NF-
kappaB through a signaling pathway involving IkappaB
kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in
gastric cancer cells. Gastroenterology 2000; 119: 97-108
3 9 Owen RJ, Sharp S, Lawson AJ, Durrani Z, Rijpkema S, Kidd
M. Investigation of the biological relevance of Helicobacter py-
lori cagE locus diversity, presence of CagA tyrosine phospho-
rylation motifs and vacuolating cytotoxin genotype on IL-8
induction in gastric epithelial cells. FEMS Immunol Med
Microbiol 2003; 36: 135-140
4 0 Ogura K, Maeda S, Nakao M, Watanabe T, Tada M, Kyutoku
T, Yoshida H, Shiratori Y, Omata M. Virulence factors of
Helicobacter pylori responsible for gastric diseases in Mongo-
lian gerbil. J Exp Med 2000; 192: 1601-1610
4 1 Akanuma M, Maeda S, Ogura K, Mitsuno Y, Hirata Y, Ikenoue
T, Otsuka M, Watanabe T, Yamaji Y, Yoshida H, Kawabe T,
Shiratori Y, Omata M. The evaluation of putative virulence
factors of Helicobacter pylori for gastroduodenal disease by
use of a short-term Mongolian gerbil infection model. J Infect
Dis 2002; 185: 341-347
4 2 Day AS, Jones NL, Lynett JT, Jennings HA, Fallone CA, Beech
R, Sherman PM. cagE is a virulence factor associated with
Helicobacter pylori-induced duodenal ulceration in children. J
Infect Dis 2000; 181: 1370-1375
4 3 Sheu SM, Sheu BS, Yang HB, Li C, Chu TC, Wu JJ. Presence of
iceA1 but not cagA, cagC, cagE, cagF, cagN, cagT, or orf13 genes
of Helicobacter pylori is associated with more severe gastric in-
flammation in Taiwanese. J Formos Med Assoc 2002; 101: 18-23
4 4 Sadakane Y, Kusaba K, Nagasawa Z, Tanabe I, Kuroki S,
Tadano J. Prevalence and genetic diversity of cagD, cagE, and
vacA in Helicobacter pylori strains isolated from Japanese
patients. Scand J Gastroenterol 1999; 34: 981-986
4 5 Kawamura O, Murakami M, Araki O, Yamada T, Tomizawa
S, Shimoyama Y, Minashi K, Maeda M, Kusano M, Mori M.
Relationship between gastric disease and deletion of cag patho-
genicity island genes of Helicobacter pylori in gastric juice. Dig
Dis Sci 2003; 48: 47-53
Science Editor Li WZ  Language Editor Elsevier HK
1950           ISSN 1007-9327     CN 14-1219/ R     World J Gastroenterol     April 7, 2005   Volume 11   Number 13
